. Author manuscript; available in PMC: 2016 Mar 1.

Published in final edited form as: Clin Nucl Med. 2015 Mar;40(3):e196–e200. doi: 10.1097/RLU.0000000000000691

Table 3.

PET/CT Parameters and Adjusted Odds of HPV+ Status (n=39)

PET/CT Parameters High vs. Low	Odds Ratio (95% CI)	P-value
Tumor SUV max	0.4 (0.09–1.78)	0.231
Tumor SUV mean	0.49 (0.11–2.09)	0.336
Tumor SUV peak	0.49 (0.09–2.64)	0.404
Tumor MTV	0.52 (0.1–2.75)	0.439
Tumor TLG	0.81 (0.17–3.84)	0.788
Tumor N SAM	0.13 (0.01–1.23)	0.075
Tumor SAM	0.56 (0.11–2.85)	0.484
Nodal SUV max	9.67 (1.61–58.03)	0.013
Nodal SUV mean	10.48 (1.82–60.36)	0.009
Nodal SUV peak	9.67 (1.61–58.03)	0.013
Nodal MTV	14.52 (2.05–102.98)	0.007
Nodal TLG	11.84 (1.50–93.74)	0.019
Nodal N SAM	16.21 (2.09–125.61)	0.008
Nodal SAM	16.21 (2.09–125.61)	0.008

Separate models were run for each PET/CT parameter adjusting for sex and age.

HPV, human papillomavirus; SUV, standardized uptake values; MTV, metabolic tumor volume; TLG, total lesion glycolysis; N SAM, normalized standardized added metabolic activity; SAM, standardized added metabolic activity; CI, confidence interval.